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Summary Although p-phenylenediamine (PPD) has been recognized as an extreme sensitizer
for many years, the exact mechanism of sensitization has not been elucidated yet.
Penetration and the ability to bind to proteins are the first two hurdles that an allergen
has to overcome to be able to sensitize. This review is anoverviewof studies regardingPPD
penetration through skin (analogues) and studies on the amino acids that are targeted
by PPD. To complete this review, the auto-oxidation and N -acetylation steps involved
in PPD metabolism are described. In summary, under normal hair dyeing exposure
conditions, <1% of the applied PPD dose penetrates the skin. The majority (>80%) of
PPD that penetrates will be converted into the detoxification products monoacetyl-PPD
and diacetyl-PPD by the N -acetyltransferase enzymes. The small amount of PPD that
does not becomeN -acetylated is susceptible to auto-oxidation reactions, yielding protein-
reactive PPD derivatives. These derivatives may bind to specific amino acids, and some of
the formed adducts might be the complexes responsible for sensitization. However, true
in vivo evidence is lacking, and further research to unravel the definite mechanism of
sensitization is needed.
Key words: haptenation; penetration; p-phenylenediamine; protein binding;
sensitization.
p-Phenylenediamine (PPD) is an aromatic amine known
for its extreme sensitizing potency, and may cause severe
allergic contact dermatitis. It is predominantly used as
a precursor in oxidative hair dyes, but it can also be
found in so-called ‘temporary henna tattoos’, despite
the prohibition of this application in Europe and the
United States (1, 2). Hair dyeing – in both consumer
and occupational settings – has been shown to be a
common cause of PPD sensitization (3). Whereas allergic
contact dermatitis in consumers gives rise to erythema
and oedema (sometimes severe) of the face, eyelids, scalp,
and neck, the hands are most affected in hairdressers (4).
Although allergic contact dermatitis caused by PPD
has been studied extensively, the exact pathways of
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sensitization and elicitation are not yet completely
unravelled. Nevertheless, as is generally known, in order
to induce a T cell-mediated immune response, a chemical
needs to undergo several steps. Briefly, a chemical has
to penetrate the stratum corneum to reach the living
epidermis. Here, the low molecular weight chemical,
the hapten, will haptenate (i.e. be bound to) cutaneous
protein. The hapten–protein complex will be formed
inside the cell or be taken up and subsequently processed
by antigen-presenting cells of the epidermis or dermis.
These cells become activated and migrate to regional
lymph nodes, where they may encounter and activate
allergen-specific naı¨ve T cells. Expanded progeny of these
allergen-specific T cells, which are then turned into
effectorandmemoryTcells,will recirculateandmigrate to
the skin. On re-exposure to the initial allergen, the above-
mentionedprocesswill recur, but nowmemoryT cells can
immediately release cytokines and chemokines, leading
to the clinical features of allergic contact dermatitis. These
general principles have been summarized extensively by
Rustemeyer et al. (5).
© 2013 John Wiley & Sons A/S
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Although PPD is a common contact allergen, it has
some special, specific properties, which make it such
an interesting allergen. This article will focus on PPD-
specific penetration and haptenation processes, that is,
events prior to the activation of antigen-presenting cells
and subsequent T cell stimulation. Although the latter
two steps are also essential in sensitization, they are
beyond the scope of this review. Regarding penetration,
an overview of the amount of PPD that becomes available
to affect the immune system will be given, whereas for
haptenation, the targeted amino acids will be shown.
Penetration
A chemical that comes into contact with the human skin
has to penetrate the skin barrier in sufficient quantities
to be able to perform its immunogenic task (6). The
stratum corneum plays the largest role in the physical
barrier function of the skin (7). This is confirmed by
studies on ‘tape stripping’, wherein the removal of the
stratum corneum leads to an enormous increase in
the absorption of chemicals (8). To a lesser extent, the
epidermis also contributes to the barrier function by
means of its desmosomal, junctional and cytoskeletal
structures (7). For penetration of the highly protective
stratum corneum barrier, several conditions have to
be met. Molecular size has been regarded as one of
the most important determinants. Bos and Meinardi
argued that the molecular weight (MW) of a chemical
must be <500 to allow skin absorption, because larger
molecules are uncommon as contact sensitizers, and
the most commonly used agents in dermatotherapy
and transdermal drug-delivery systems have MWs of
<500 (6). Although low-MW chemicals penetrate more
easily, largermolecules suchas proteins have been shown
to be able to pass the stratum corneum (9, 10). Next
to molecular size, lipophilicity – often expressed as a
partition coefficient (log Poctanol/water) – and non-polarity
are considered to be important physicochemical factors
positively influencing percutaneous absorption (11–13).
Nevertheless, hydrophilic, polar substances are also
able to penetrate the skin. Theoretically, chemicals
can penetrate the epidermal barrier via two distinct
pathways: the transepidermal route, whereby the
chemical penetrates intercellularly or intracellularly; or
via diffusion along sweat glands and pilo-sebaceous
follicles, the so-called ‘shunt pathway’ or follicular
penetration. Whereas the extent of the contribution
to transdermal delivery of the latter pathway is
discussed (14, 15), and it is proposed that chemicals use
several pathways simultaneously (16), the intercellular
pathway is generally considered to be the predominant
route of penetration (17–20). The intercellular matrix
surrounding the corneocytes consists of lipid bilayers,
which are organized in such a way that both lipophilic
and hydrophilic domains, sometimes called ‘hydrophilic
pores’, are formed, allowing the penetration of non-
polar and polar molecules respectively (21–23). Less
evidence is available for intracellular penetration (13,
24), although corneocytes may provide a hydrophilic
pathway, owing to their protein content. Besides a
chemical’s physicochemical parameters, several other
factors are important in determining skin penetration.
Exogenous factors such as extensive exposure to
detergents and physical damage (e.g. irradiation or
abrasion) impair the skin, and thismay lead to irritationor
even irritant contact dermatitis (25), which, in turn, has
been demonstrated to be important in the development of
allergic contact dermatitis (26). On the other hand, pre-
existing inflammatory skin conditions (27), atopy (28)
and loss-of-function null mutations in the gene encoding
the skin barrier protein filaggrin (FLG) are endogenous
factors known to affect the skin barrier. However,
the relationship between FLG mutations and contact
sensitization is not straightforward, as exposure may
represent the major risk factor, as suggested for
nickel sensitization (29). Furthermore, as summarized
by Berard et al., protein binding, hydration level,
anatomical differences, occlusion, age and the vehicle
usedmay influenceoverall skinpenetration (9).Although
even small amounts of allergen may be sufficient to
start the sensitization cascade, penetration remains
the prerequisite for interaction with the cutaneous
immunological cells. In the following paragraphs, the
quantitative penetration of PPD through the skin will be
discussed. In order to place these values in perspective,
the results of penetration studies on other aromatic
amines – toluene-2,5-diamine [p-toluenediamine (PTD)]
and p-aminophenol – are provided. Importantly, the
reported differences of three-fold to 11-fold (30) fall
within the commonly accepted range of interindividual
differences in humans.
Specific PPD Penetration under Typical
Exposure Scenarios
PPD is water-soluble, has a MW of 108.1, and has been
shown to penetrate the skin by detection in plasma,
urine and faeces after topical application of a PPD-
containinghairdye (31). Inatypicalhairdye formulation,
a precursor (e.g. PPD or PTD) and different couplers
(e.g. resorcinol and m-aminophenol) are mixed with
an oxidizing agent (hydrogen peroxide) under alkaline
conditions, in order to form and attach the desired
© 2013 John Wiley & Sons A/S
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colour(s) within the hair shaft. Although only a few
studies are available in the literature, they suggest
a moderate penetration enhancement effect of a high
pH (32, 33).
Hueber-Becker et al. showed that a commercial
[14C]PPD-containing oxidative hair dye, which was
applied to human volunteers for 30 min, had been
excreted predominantly (90% of the total excreted
PPD) via urine (31). It should, however, be taken
into account that excreted [14C]PPD also includes
[14C]PPD equivalents or derivatives. The majority of
these derivatives are formed through N -acetylation of
PPD to monoacetyl-PPD, which in turn is acetylated to
diacetyl-PPD by the N -acetyltransferase enzymes. This
was shown in vitro by the use of cultured keratinocytes
and cytosolic fractions of the human skin (34), and
confirmed in vivo in humans by detection of these
acetylation products in urine after the use of a PPD-
containing hair dye (31, 35, 36). The detection of the
acetylated PPD derivatives – which can only be formed
intracellularly – in the urine of subjects who dyed their
hair supports the uptake of PPD and the efficient release
of acetylated PPD products (35, 36).
The results for [14C]PPD-containing hair dyes, as well
as for PPD dissolved in petrolatum (which is commonly
used for patch testing), are summarized in Table 1.
Table 2 provides a similar overview for the other
compounds, discussed in relation to PPD penetration.
In vivo studies
Human urinary excretion. An early report by Wolfram and
Maibach in1985showedthatapplicationofacommercial
oxidative hair dye formulation containing2.7% [14C]PPD
to human scalp hair for 20 min resulted in a total
urinary excretion of 0.19% ± 0.06% of the applied dose
(Table 1), with a half-time of 16 hr (37). These data were
confirmed by Goetz et al., who examined percutaneous
absorption after hair dying (n = 5 females) with an
unlabelled PPD-containing hair dye formulation (35).
Approximately 85% of the amount recovered in 48 hr
was released during the first 24 hr. Their analytical
method allowed the determination of PPD derivatives
in urine, and the authors calculated that 80% of their
detected PPD derivatives actually consisted of diacetyl-
PPD. Taking into account the different doses used, the
total dose excretion (0.04% after 24 hr) was similar to
that of Wolfram and Maibach (Table 1) (37). Regarding
kinetics, theyobservedacetylatedPPDderivatives inurine
by 30 min after the typical dyeing procedure had been
completed. Hueber-Becker et al. used a detailed mass
balance approach, with standard operating procedures
and defined conditions, such as hair length, professional
hairdressers and the collection of clipped-off hairs,
washingwater, and usedmaterials, to investigate human
systemic exposure after application of a specifically
prepared 2% [14C]PPD-containing oxidative hair dye to
the scalp (31). This was determined by measuring the
mean radioactivity excreted in blood, urine and faeces
in different intervals, for up to 120 hr after application.
The total excretion was 0.54% ± 0.25% of the applied
dose (Table 1). Again, the majority (86%) of absorbed
radioactivity was excreted within 24 hr after application.
By using the same human subjects and experimental
conditions, Nohynek et al. showed that the majority,
namely 80–95%, of the PPD metabolites excreted via
the urine consisted of monoacetyl-PPD and diacetyl-PPD,
confirming the previous results of Goetz et al. (36). Two
recent human in vivo studies – not shown in Table 1,
because details were not available – summarized by the
ScientificCommittee onConsumerSafety (SCCS) obtained
excretion data similar to those of the previous studies.
Briefly, both studies applied a [14C]PPD-containing hair
dye (1% PPD and 2% PPD, respectively) for 30 min
to human volunteers under standardized conditions,
with the application being performed by professional
hairdressers. Urinary excretion was 0.88% ± 0.46% of
the applied dose in the 1% PPD study and 0.72% ±
0.25% of the applied dose in the 2% PPD study. The
study using 1% PPD also investigated the composition
of urinary PPD equivalents. This showed that >99%
consisted of diacetyl-PPD, and that some urine samples
contained very low levels of PPD (<0.3%) ormonoacetyl-
PPD (<0.2%). Furthermore, some of the urine samples
showed traces of the completed hair dye product (trimer)
and of the monoacetylated trimer (45). The values found
in the above-mentioned studies are well in line with
the values found for PTD, another hydrophilic aromatic
amine that is also used as a precursor in oxidative hair
dyes (Table 2). Topical application of a PTD-containing
(home-made) hair dye to human volunteers for 40 min
resulted in urinary excretion of 0.18% of the applied
amount (estimated at 3571 μg/cm2) (42). The urinary
excretion peaked in the 4 hr post-application, and 90% of
all the excreted PTD equivalents over a period of 48 hr
were detected within 24 hr.
Human plasma levels. Hueber-Becker et al. additionally
examined plasma concentrations, and showed that
the maximal PPD levels (Cmax) of 0.087 μgeq/ml (i.e.
0.0046%of theapplieddoseper cm2)were foundat∼2 hr
(Tmax)afterdyeing,whereasafter24 hrnomore [14C]PPD
equivalents could be detected (31). This is in accordance
with the urinary excretion of PPD, which has also been
© 2013 John Wiley & Sons A/S
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shown to bemost frequently completedwithin 24 hr. The
two studies summarized by the SCCS (45) also examined
PPD equivalent plasma kinetics following the hair dye
application. It was shown, for both concentrations (1%
PPD and 2% PPD), that the respective Cmax values of
0.0974 and 0.133 μgeq/ml were found at a Tmax of
2 hr, which is in concordance with the study performed
by Hueber-Becker et al. Furthermore, in the hair dye
procedure with 1% PPD, it was shown that the PPD
equivalents in plasma consisted of diacetyl-PPD, and no
PPD or monoacetyl-PPD was detected. A few plasma
samples showed traces of the completed hair dye products
(or their acetylated part) at amounts slightly above their
lower limits of quantification.
Animal urinary excretion. In addition to the human scalp,
Wolfram and Maibach applied the 2% [14C]PPD-
containing oxidative hair dye to the scalp of rhesus
monkeys (37). The total urinary excretion of 0.18% ±
0.06% was similar to the excretion values for humans
(0.19% ± 0.06%; collection time for both species up
to 144 hr; Table 1). Again, these values were similar
to those following PTD application, with 0.09% of the
applied dose (2000 μg/cm2) and 0.14% of the applied
dose (833 μg/cm2) being excreted in the urine by dogs
and rats, respectively (Table 2) (43).
Animal plasma levels. Dressler and Appelqvist investigated
the plasma pharmacokinetics of dermal PPD exposure in
rats (38). Three male and three female rats, clipped free
of hair, were exposed under occlusion to 200 μg/cm2
[14C]PPD solution for 4 hr. Analysis of plasma taken
after 4 hr showed the exclusive presence of diacetyl-
PPD. In males, the mean plasma level was 1.41 ±
0.34 μgeq/ml (0.71% of the applied amount per cm2),
whereas in females a higher mean plasma level of
7.40 ± 1.83 μgeq/ml was reached (3.7% of the applied
amount per cm2), which was not be attributable to a
true sex difference, but to the difference in body weight
(Table 1) (38). For p-aminophenol, another hydrophilic
aromatic amine used in hair dyes and investigated in
this study, the mean maximal plasma level at Tmax 4 hr
of 0.50 μgeq/ml, corresponding to 0.67% of the applied
amount per cm2, was similar to the level of PPD, despite
different experimental conditions (Table 2) (38).
Summarizing these in vivo data, it can be stated that,
under simulated hair dye conditions, 0.04–0.88% of
the applied PPD-containing dye formulation is excreted.
Whereas the Hueber-Becker et al. study was the only
one to investigate both urinary and faecal excretion,
they showed that absorbed PPD is excreted primarily
(>90%) via urine. Furthermore, these data show that
most of the absorbed PPD had been excreted within
24 hr. Nevertheless, a study by White et al. showed
persistence of PPD equivalent in the stratum corneum
for as long as 3 days after an only very short application
(5 min) of a PPD-containing hair dye (46). The PPD was
probably bound to the keratins, as these are the major
proteins in the stratum corneum. This part may then
act as a reservoir, although limited in duration, as the
turnover time of the stratum corneum is ∼2 weeks (47).
However, the relevance of a PPD reservoir in the
stratum corneum for sensitization remains unknown,
as the amount of PPD bound to this layer under hair
dye conditions and the release capacity have not been
established. Penetration through the skin, and hence the
appearance in plasma and urine, was monitored shortly
after the hair dyeing procedure, and PPD metabolites
were found in urine by 30 min after completion of the
dyeing procedure. Moreover, the majority of excreted
PPD was found to have been acetylated to monoacetyl-
PPD and diacetyl-PPD. Three studies examined human
in vivo plasma concentrations, and all showed that PPD
equivalents reachedmaximal plasmaconcentrations2 hr
after application of the hair dye. Animal plasma levels
were somewhat higher than human plasma values,
probably reflecting the longer application time, the
different formulation, or the higher level of penetration
through rat skin than through human skin (30). The
relatively low amount of PPD that had penetrated, and
was hence considered to be bioavailable (0.04–0.88% of
the applied dose), in the in vivo experiments resembling
conditions of permanent hair dyeing are well in line with
the reviewed data on percutaneous absorption of PTD
and p-aminophenol, as well as with data for many other
oxidative hair dye amines compiled by Platzek (48).
In vitro and ex vivo studies
In vitro study: human reconstructed epidermis model. In general,
penetration is considered tobehigher in thesemodels than
in in vivo experiments. This points to incomplete barrier
function in these models (49, 50). Hu et al. investigated
the transformation of various amounts of PPD and
p-aminophenol in the EpiDerm™ model, consisting of
human reconstructed epidermis (39). Topical application
was studied in the case of p-aminophenol, whereas both
topical application and exposure via culture medium
were examined in the case of PPD. Both PPD and
p-aminophenol exposure resulted in dose-dependent N -
acetylation. p-Aminophenol (total recovery in medium
of 9%; Table 2) was completely acetylated within 24 hr
following topical application of 87 μl of 100 μM p-
aminophenol (equivalent to 1.5 μg/cm2). Recovery of
© 2013 John Wiley & Sons A/S
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PPD and its acetylated metabolites in medium following
24 hr of exposure via cell culture medium showed ∼80%
acetylated compounds with 20 μM PPD, whereas the
presence of 1000 μM resulted, donor-dependently, in
75–86% recovery of the unmodified parent compound.
In the middle range, with 24 hr of exposure to 1 ml of
100 μMPPD(equivalent to11 μg/mlPPD),approximately
50–70% was metabolized to acetylated products. For
30-min topical applications, a similar concentration-
dependent decline in acetylation was seen. Whereas
topical exposure to 100 μM PPD resulted in complete
acetylation with no parent PPD left, application of the
highest PPD amount tested (2500 μM, corresponding to a
dose of 36.7 μg/cm2) with subsequent rinsing, followed
by a 23.5-hr recovery period of the model in culture
medium, resulted in 7.1% acetylation (recovery: 1.2%
as monoacetyl-PPD, 5.9% as diacetyl-PPD and 5.3% of
unmetabolized PPD within 24 hr) (12.5% recovery in
total; Table 1). The observed reduction of acetylation in
the presence of increasing PPD concentrations points
to enzyme saturation and inhibition of N -acetylation
capacities (39). This modulation was also shown in an
immortalized keratinocyte cell line (HaCat) and in normal
human epidermal keratinocytes by Bonifas et al. (51).
It is very likely that, also in the case of application of
temporary black henna tattoos, saturation of the N -
acetylation pathway occurs, as a high concentration of
PPD is often added and PPD is present on the skin for a
long period (52, 53).
Human and animal ex vivo studies. Goebel et al. compared
exposure levels of [14C]PPD under different conditions,
usingpig skin samples inflow-throughdiffusioncells (40).
A 48-hr occlusive PPD patch test (dose of 400 μg
PPD/cm2) was compared with a simulated 30-min open
hair dyeing procedure (dose of 3000 μg PPD/cm2). The
total absorption, measured in the stratum corneum,
epidermis,dermis,andreceptorfluid,was205.1 μgeq/cm2
(51.3% of the applied dose) for the patch test, and
6.8 μgeq/cm2 (0.23% of the applied dose) for the hair
dye formulation (Table 1). A lower dose (± 400 μg/cm2),
with a very similar hair dyeing approach and with the
use of both human abdominal and pig ear skin, was
tested by Hueber-Becker et al. (Table 1) (31). Twenty-
four hours after a 30-min open application procedure,
the amount of PPD that had penetrated was determined
in the skin and in the receptor fluid. The total amount
per surface area absorbed could then be calculated at
16.1 μgeq/cm2 (3.71% of the applied dose) for human
skin, and 21.9 μgeq/cm2 (5.1% of the applied dose) for pig
skin, which is ∼10-fold higher than the values in their
in vivo study (total absorption of 0.54% of the applied
dose) and also in line with the hair dye formulation of
Goebel et al. (0.23% of the applied dose) (40). Another
human ex vivo study, summarized by the SCCS (not
included in Table 1), examined percutaneous absorption
of [14C]PPD in the presence or absence of other dyes, of a
developer, and/or of humanhair, with PPD doses ranging
from 540 to 2700 μg/cm2. Remarkably, the penetration
in all conditions was between 0.1% and 0.2% of the
applied dose, and the presence of hair on the surface did
not significantly influence penetration (45). In a study
of Steiling et al., 30 min of application of a [14C]PPD-
containing hair dye formulation resulted in recovery of
4.59% of the applied dose in the skin and receptor fluid
(Table 1) (41). In conclusion, the experiments modelling
hair dye conditions (similar exposure time of 0.5 hr and
using an oxidative hair dye formulation) showed total
absorption of 0.23–5.1% of the applied dose when ex vivo
pig skin was used, and 0.1–3.71% when ex vivo human
skin was used. These values are in concordance with
calculated absorption rates ranging from0.04% to0.88%
of theapplied dosewhen in vivohumanskinwasused. The
useofadifferentcondition – namelyapatchtestcondition
that involves occlusion, a longer exposure time of 48 hr,
andthevehiclepetrolatum – showsaconsiderable impact
on the absorption, which could be calculated at 51.3% of
the applied dose. For PTD percutaneously applied to pig
skin, absorption values were similar to PPD values, and
ranged fromapproximately0.23%to2.39%of theapplied
dose, whereas 3.4% of the applied dose penetrated ex vivo
humanskin (Table 2) (44). The ‘measured exposure level’
(MEL) provides a better estimate of the actual exposure
than calculating the amount of the applied dose that has
penetrated.TheMEL,consistingof theamountofchemical
in the stratum corneum, epidermis, dermis, and receptor
fluid, was introduced by Goebel et al. (40), but could also
be calculated for three other studies on the basis of the
dataprovided (Table 1).TheseMELsagainshowthemajor
impact of exposure time, as the higher MEL for the patch
test application was obtained with a dose similar to the
dose used in the studies of Hueber-Becker et al., which
resulted in 10-fold lower MELs (31).
Conclusions
Despite the different conditions used (i.e. formulation,
species, and applied doses) in the reviewed PPD studies,
the penetration values after a short exposure time of
∼0.5 hr are quite similar. When considering daily life
exposure to PPD (e.g. hair dyeing), one may consider
that 0.04–0.88% of the applied dose penetrates the skin.
Furthermore, the reviewed studies indicate that PPD is
metabolized to monoacetyl-PPD and diacetyl-PPD, but
© 2013 John Wiley & Sons A/S
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that N -acetylation capacities decrease with increasing
doses of PPD.
Although only small amounts of PPD penetrate the
skin during a 0.5-hr exposure, this is enough to induce
sensitization in susceptible individuals, as well as to
elicit allergic contact dermatitis in previously sensitized
subjects (54, 55). This may relate to potency and/or
to the short timescale of immunological events after
topical application (56). Although penetration remains
a prerequisite, the chemical and protein reactivity of a
chemical have been proposed to be major determinants
for the induction of contact sensitization. Therefore, they
form the subject of the following part of this review.
Chemical Reactivity and Protein Binding
To date, the murine local lymph node assay (LLNA) has
been considered to be the preferred skin sensitization
prediction model (57). However, the clear need for non-
animal-based methods has resulted in the development
of a wide variety of in vitro, in silico and in chemico
approaches for risk assessment. All of these methods
refer to one of the key steps in the sensitization
cascade: allergen penetration, binding to proteins (i.e.
haptenation), stimulation of antigen-presenting cells,
or T cell proliferation (58). Nevertheless, recent studies
have shown that the reactivity of the hapten with
peptides or proteins is a major determinant in predicting
allergenic potency (56, 57, 59). Actually, the protein
reactivity of the allergens investigated thus far has
been shown to correspond very well with the allergen’s
sensitizing potency as determined by the LLNA’s EC3
value (the concentration giving a stimulation index of
3) (60–62). This correlation between protein reactivity
and sensitization has been known for many years. In
1935, Landsteiner and Jacobs described the classical
‘hapten concept’, which stated that a chemical needs to
bind covalently to skin proteins to form hapten–protein
complexes in order to become immunogenic and to
start the sensitization cascade (63). In addition to this
initial hapten concept regarding skin sensitization, the
pro-hapten and pre-hapten concepts arose. The pro-
hapten concept states that chemicals that are initially
not chemically reactive towards proteins have to be
metabolized before being able to haptenate proteins
and to become immunogenic (64). Nevertheless, as
discussed by Lepoittevin, not all non-protein-reactive
chemicals are transformed enzymatically; some are, for
example, non-enzymatically oxidized (65). He therefore
suggested a modification of the concept, and introduced
the pre-hapten concept, for ‘non-reacting sensitizing
molecules transformed into haptens by simple chemical
transformation and without requirement of a specific
enzymatic system’. Considering that, depending on the
environmental conditions, pre-haptens may behave as
pro-haptens, and that there are no validated methods
to distinguish a pre-hapten from a pro-hapten in vivo
or ex vivo, the use of these distinctive concepts has
been challenged (66, 67). Nevertheless, they are still in
commonuse to describe the different pathways needed for
a chemical to haptenate proteins.
Even though several complex chemical mechanisms
may underlie the haptenation process, it is thought
to mainly occur through an electrophilic–nucleophilic
interaction. The electrophilic moieties on haptens enable
them to covalently interact with nucleophilic side chains
of amino acids of cutaneous proteins (59, 68). In recent
years, several chemical reactivity assays have been
developed (57,61,62,69–75).Most of themmeasure the
depletion of the protein or peptide, that is, thenucleophile.
However, additional analysis of the formed adducts may
provide supplementary information on reactivity, and
can exclude false-positive peptide depletion results based
on chemical-induced peptide dimerization (71, 76). The
experimental nucleophilic compound often consists of a
mixture of amino acids, is a synthetic model peptide, or
is a naturally present protein, such as human serum
albumin (HSA) or glutathione (GSH) (77). There are
several analytical methods available to detect adduct
formation with exact localization of protein modification,
as well as to determine nucleophile depletion; these have
been elegantly summarized by Gerberick et al. (78). In
addition to the existing peptide-based reactivity assays,
Gerbericket al. introducedanassay integratingenzymatic
activity, allowing the detection of pro-haptens (68). This
is an important addition, considering the fact that at
least one-third of the known sensitizers are believed to
be not directly protein-reactive (79). Furthermore, it is
probable that not all hapten–protein adducts formed
are immunogenic, but, to date, studies investigating this
are lacking. Although the side chains of many amino
acids in protein contain nucleophiles that are capable
of reacting with electrophilic allergens, in vitro data
suggest that chemicals show selectivity in their amino
acid preference (70, 80–82). In fact, although histidine,
methionine and tyrosine can react with electrophiles (64,
69), reactivity assays using cysteine and lysine show the
highest depletion and a stronger correlation with LLNA
EC3 values (61, 62, 71).
Haptenation: What is Known about PPD
PPD is regarded as not directly protein-reactive (i.e.
non-electrophilic) (72), and may be classified as pre-
hapten (68). In general, there is not much certainty
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Fig. 1. Overview of the proposed penetration and conversion of p-phenylenediamine (PPD) on and in the skin (model). PPD is known to
penetrate the skin, and here it is subjected to N -acetylation or oxidation. Oxidation of PPDmay lead to the formation of a
p-benzoquinonediimine intermediate (p-BQDI), which may be transformed into p-benzoquinone (p-BQ) through hydrolysis, or into
Bandrowski’s base (BB) through several oxido-conjugation reactions. These PPD oxidation derivatives have been shown to react with amino
acid residues of proteins (in in vitro experiments), and might be the complexes responsible for sensitization. N -acetylation, on the other hand,
will formmonoacetyl-PPD (MAPPD) and diacetyl-PPD (DAPPD), which are considered to be non-sensitizing compounds (in the local lymph
node assay). Skin conditions may allow the formation of the oxidized derivatives on the skin surface, although their penetration into the skin
might be limited, because of their reactivity. Thick arrow: significant penetration. Dotted arrows: proposed steps, not confirmed in vivo.
regarding either the nature of the hapten–protein
complex or the way in which it stimulates immune
cells (75, 77, 78). For PPD, it is even harder to
predict the interaction with protein, owing to its
intrinsic instability and rapid auto-oxidation when
it is exposed to oxygen in air or is present in
aqueous solution. Its primary oxidation product, p-
benzoquinonediimine, is susceptible to sequential oxido-
conjugation reactions, ultimately leading to formation
of the trimer Bandrowski’s base (Fig. 1). In addition to
PPD, p-benzoquinonediimine, and Bandrowski’s base,
Aeby et al. found another dimeric structure and two
trimeric structures (83). This was, however, achieved
after in vitro experiments with exaggerated oxygenation.
Furthermore, p-benzoquinonediimine is susceptible to
hydrolysis, generating p-benzoquinones (72) (Fig. 1). As
well as thisnon-enzymatic formationof reactiveoxidation
products, PPD has been shown to be enzymatically
converted into the acetylation products monoacetyl-PPD
and diacetyl-PPD by N -acetyltransferase 1 (NAT1),
a phase II enzyme that is abundant in epidermal
keratinocytes (34) (Fig. 1). In contrast to the oxidized
derivatives of PPD, the acetylated products monoacetyl-
PPD and diacetyl-PPD are negative in the LLNA
(standard LLNA according to Organization for Economic
Co-operation and Development, guideline 429) (83).
Furthermore, they have been shown to be incapable
(monoacetyl-PPD) or less capable (diacetyl-PPD) of
eliciting allergic reactions when PPD-sensitized subjects
are patch tested (84). However, the acetylation capacities
of keratinocytesmay become saturated or inhibited under
certain circumstances (51, 85). Hence, disturbing the
precarious balance between acetylation and oxidation
might be critical in inducing sensitization to PPD (83).
Furthermore, because of PPD’s instability and the
excellent auto-oxidation conditions provided by the air-
exposed skin surface, it is very possible that PPD already
oxidizes before it enters the skin and before it has the
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chance to become acetylated (Fig. 1). It has been shown
in vitro that, 30 min after exposure to oxygen in air,
another monomer, possibly p-benzoquinonediimine, can
already be detected (83). This may thus expose the skin
to the highly protein-reactive oxidized intermediates,
although p-benzoquinonediimine might be considered
to be too reactive to penetrate the stratum corneum (72,
83). For Bandrowski’s base, the penetration may also be
limited, at least for human patch test conditions with
single-dose exposure, because, although Bandrowski’s
base is an extreme sensitizer in the LLNA (∼10-fold
more sensitizing than PPD) (86), and is capable of
activating dendritic (83) and THP-1 cells (87) in vitro and
stimulating T cell proliferation of PPD-allergic patients
ex vivo (88), in vivo only 16% of PPD patch test-positive
patients responded weakly to Bandrowski’s base when
the latter was applied under patch test conditions (86).
Furthermore, hair dye conditions – providing an alkaline
environment with an excess of couplers and only a
limited exposure time – prompt the formation of less
permeable colouring molecules rather than the PPD
auto-oxidation products p-benzoquinonediimine and
Bandrowski’s base (89) (Fig. 1). To summarize, it is
suggested that when NAT1 acetylation capacity is not
sufficient, a range of subsequently formed PPD oxidation
products may result in the generation of a spectrum of
known and unknown electrophilic and hence antigenic
determinants (72) (Fig. 1). As well as the electrophilic p-
benzoquinonediimine, other oxidized derivatives, such as
p-benzoquinone, Bandrowski’s base, and PPD itself, have
been subjected to protein reactivity assays. Nevertheless,
when studying PPD in these assays, one has to bear in
mind that PPD itself is not protein-reactive, and that,
actually, one of the auto-oxidation derivatives, probably
the primary oxidation product p-benzoquinonediimine,
reacted to the investigated protein (90).
PPD Intermediates Reacting with Amino Acids
Eilstein et al. were able to show that 2,5-[13C]-dimethyl-
substituted p-benzoquinonediimine reacted with several
nucleophilic amino acids (e.g. N -acetyl-cysteine, N -
acetyl-tryptophan, and N -acetyl-lysine) through a set of
complexchemicalmechanisms (72).The two13C-labelled
methyl groups were introduced on the aromatic ring of
p-benzoquinonediimine, because this facilitates the study
of its protein reactivity by specific mass spectrometric
techniques.Whereas cysteinewas directly and covalently
bound to 2,5-[13C]-dimethyl-p-benzoquinonediimine,
tryptophan and lysine were first subjected to oxidation
and reduction processes. The authors concluded that
the formed adducts deserved serious consideration as
potential antigenic structures responsible for contact
sensitization (72). In 2007, this group published the
results of a follow-up study, wherein the specific
reactivity of 2,5-[13C]-dimethyl-p-benzoquinonediimine
towards lysine was investigated. The authors studied
lysine in particular, because of its proposed key role
in contact sensitization (82), together with the fact
that cysteine reactivity does not necessarily relate to
sensitizing potential, and the results of an in vitro study
showing that, intracellularly, thiol groups of cysteine
were less abundant than amino groups of lysine (73).
They showed once more that, besides the known
classical electrophilic–nucleophilic mechanism, complex
oxidoreduction processes were observed. Actually, the
2,5-[13C]-dimethyl−p-benzoquinonediimine oxidatively
removed the amine group from lysine, revealing
the reactive intermediate that is capable of adduct
formation. Consequently, the authors concluded that,
in addition to the direct covalent hapten–protein
coupling, oxidative modification of proteins induced by
p-benzoquinonediimine is an important determinant
in the formation of antigenic structures, and hence
could be relevant in sensitization to PPD (73). Likewise,
Aptula et al. described two parallel chemical reaction
mechanisms, thereby particularly emphasizing the
importance of the free radical binding mechanism in the
skin sensitization properties of PPD (91). They designated
thesulfhydryl (SH)group (of cysteine)as themajor reactor
in hapten–protein binding (91). The reactivity towards
amino acids has also been examined for other PPD
intermediates. Peptide depletion assays showed that p-
benzoquinone depleted lysine, cysteine, andhistidine (62,
70, 92, 93), whereas the trimer Bandrowski’s base
was shown to deplete cysteine and, to a lesser extent,
lysine (62, 93). PPD was shown to react with lysine,
cysteine, histidine, and arginine (71, 92). However,
as discussed and shown by adduct analysis (90), the
compound responsible for this reactivity should actually
be assumed to be p-benzoquinonediimine or another
oxidized derivative of PPD.
PPD Intermediates Reacting with Peptides
By studying the exploratory compound 2,5-[13C]-
dimethyl−p-benzoquinonediimine with a cysteine-free
model peptide (resembling the N-terminal chain of the
globin protein), Eilstein et al. confirmed their previous
findings on the reactivity of this compound with
lysine (74). Cysteine was excluded because of the known
high reactivity of the thiol (SH) groups with allergens;
exclusion of cysteine would potentially allow other
amino acids to react. Furthermore, in this way, the
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easily occurring cysteine dimerization was also avoided.
Jenkinson et al. showed that in a more complex
chemical environment (using model peptide DS3),
p-benzoquinonediimine, as well as 2,5-dimethyl−p-
benzoquinonediimine, were found to bind exclusively to
cysteine, via a classical nucleophilic–electrophilic reac-
tion (75). These experiments addressed the major effects
of the environment on the binding capacity of a chemical.
Thiscapacity ishighly influencedbythepHof themicroen-
vironment, which, in turn, is dependent on the presence
of surrounding amino acids. Currently, it is unknown
whether hair dyeing can affect the pH in the skin layers,
such that it is relevant for haptenation. In addition to
p-benzoquinonediimine, the derivative p-benzoquinone
was studied, and was shown to cause depletion of GSH,
which was used as a cysteine-containing peptide (62).
PPD Intermediates Reacting with Model Proteins
In order to further characterize the specific amino
acid modification of p-benzoquinonediimine, Jenkinson
et al. used the His-tagged glutathione S-transferase π
(His-GSTP) protein, and showed that both p-benzoqui-
nonediimine and 2,5-dimethyl−p-benzoquinonediimine
selectively and exclusively modified Cys47 (75). No other
cysteines (i.e. Cys14, Cys17, Cys101, and Cys169) were
modified, reflecting their difference in reactivity caused by
the specific physicochemical parameters. This exclusive
binding to cysteine is in line with the results obtained
with the model peptide DS3. Besides His-GSTP, Jenkinson
et al. investigated the possible binding sites of PPD on
HSA (94). They showed that PPD irreversibly bound to
HSA at Cys34, but not to lysine and tryptophan, which
also indicates that this covalentmodification of cysteine is
favoured over the other possible pathways. A mass spec-
trometric analysis suggested that a single molecule of the
primary PPD oxidation product,p-benzoquinonediimine,
had been added to HSA.
Conclusions
The modification of cutaneous proteins by a hapten is
considered to be one of the prerequisites for the induction
of contact sensitization, and this correlation has been
acknowledged for many years. Therefore, a variety of
protein reactivity assays have been designed, often using
peptide depletion or adduct formation as outcome param-
eters. Specificmass spectrometric techniques have shown
preferred amino acids, although this has been shown to
be largely dependent on the microenvironment. There-
fore, it should be stressed that these assays only predict
in vitro reactivity, and that the in vivo relevance of these
adducts cannot be determined straightforwardly. In fact,
this might be true for p-benzoquinone and Bandrowski’s
base. Although both substances are positive in the LLNA
and have been shown to form adducts with proteins
in vitro, clinical studies suggest that they are not impor-
tant in allergic contact dermatitis caused by PPD (86).
Several studies have shown the distinctive, complex
mechanisms responsible for adduct formation. Whereas
direct covalent binding through electrophilic–nucleo-
philic interactions was often observed, complex oxi-
doreduction reactions were also shown to be involved.
In the case of PPD, the (known) protein-reactive oxi-
dized intermediates consist of p-benzoquinonediimine,
p-benzoquinones, and Bandrowski’s base, which were
most often found to react with cysteine and lysine,
although histidine, arginine and tryptophan might also
play a role in the haptenation process. Some authors (69,
75, 94) found that PPD or p-benzoquinones exclu-
sively bound to specific cysteines in experiments using
model peptides and proteins, and therefore suggested
that cysteine may be an essential amino acid in con-
tact sensitization to PPD. As discussed by Divkovic et al.,
prediction of the immunogenicity of particular protein
modifications and, especially, determination of the exact
peptide fragments that are presented to the naı¨ve T cells
would be extremely helpful in predicting the hapten’s
in vivo allergenic effect (77). Moreover, it has been widely
acknowledged that a combination of data from in silico,
in vitro and in chemico assays will be required to predict
skin sensitization potential as accurately as possible (58,
92). The first attempt at such a combined approach has
been made (92).
Concluding Remarks
As shown by the studies that have been reviewed, PPD
remains an intriguing allergen because of its unstable
character, which allows the formation of several protein-
reactive auto-oxidation products. On the other hand, the
human body seems to be very well protected against the
formation of these potentially harmful oxidation prod-
ucts, by converting PPD into the detoxification products
monoacetyl-PPD and diacetyl-PPD. The penetration of
PPD has been shown to be dependent on the conditions
used, especially the exposure time. The small amount
of PPD that penetrates after application to the skin
(with the use of hair dye formulations and conditions),
together with the fact that the majority of it becomes
acetylated, shows the strong sensitizing potency of the
remaining oxidized PPD derivatives. This is reflected in
the prevalence figures. Whereas, in unselected dermati-
tis patients, the prevalence of PPD sensitization ranged
from 1% to 6%, the prevalence increased to 38–97%
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in a highly selected hair dye dermatitis population, as
shownbya literature reviewconcerningEuropean,North
American and Asian data (95). Although, for the in vivo
situation, it is still not completely determined which
amino acids PPD preferentially binds to, the results of
several studies discussed in this review give important
clues. However, theremay bemany unknown (oxidative)
PPD derivatives, the impact of which is unpredictable.
Thus, further experiments to define the specific antigenic
adducts responsible for naı¨ve T cell activation are needed
to improve our understanding of the mechanism of PPD
sensitization.
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